All Stories

  1. RhoA, RhoB and RhoC differentially regulate endothelial barrier function
  2. A CDC42-centered signaling unit is a dominant positive regulator of endothelial integrity
  3. Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
  4. Multiple confusing names for endothelial progenitors
  5. Physiology of blood vessels
  6. Mast cells are increased in the media of coronary lesions in patients with myocardial infarction and may favor atherosclerotic plaque instability
  7. Transdifferentiation of Human Dermal Fibroblasts to Smooth Muscle-Like Cells to Study the Effect ofMYH11andACTA2Mutations in Aortic Aneurysms
  8. Osteoglycin’s embracement of VEGF receptor-2 limits angiogenesis and collateralization
  9. Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function
  10. Perivascular fat in human muscle
  11. Identification of HIF-2α-regulated genes that play a role in human microvascular endothelial sprouting during prolonged hypoxia in vitro
  12. Therapeutic Potential of Human-Derived Endothelial Colony-Forming Cells in Animal Models
  13. Correction: HIF-2α Expression Regulates Sprout Formation into 3D Fibrin Matrices in Prolonged Hypoxia in Human Microvascular Endothelial Cells
  14. Traction force dynamics predict gap formation in activated endothelium
  15. HIF-2α Expression Regulates Sprout Formation into 3D Fibrin Matrices in Prolonged Hypoxia in Human Microvascular Endothelial Cells
  16. Development of a new therapeutic technique to direct stem cells to the infarcted heart using targeted microbubbles: StemBells
  17. CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs)
  18. C1q/TNF-related protein 1: a novel link between visceral fat and athero-inflammation
  19. Angiogenesis: Basics of Vascular Biology
  20. Neovascularization of the atherosclerotic plaque
  21. Platelets and thromboxane receptors: pivotal players in arteriogenesis: Figure 1
  22. ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension
  23. Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity
  24. Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in women
  25. Hypoxic Signaling During Tissue Repair and Regenerative Medicine
  26. Blood Vessels
  27. C57BL/6 NK cell gene complex is crucially involved in vascular remodeling
  28. Localized RhoA GTPase activity regulates dynamics of endothelial monolayer integrity
  29. Multiple Roles of Proteases in Angiogenesis
  30. Effective Treatment of Edema and Endothelial Barrier Dysfunction With Imatinib
  31. Perivascular Adipose Tissue Control of Insulin-Induced Vasoreactivity in Muscle Is Impaired in db/db Mice
  32. Tie2 lineage deletion of  6 integrin: endothelial and haematopoietic cells in neovascularization
  33. Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular fat
  34. Contribution of chronic hypoxia and circulating endothelial colony forming cells to angiogenesis
  35. Endothelial insulin receptor expression in human atherosclerotic plaques: Linking micro- and macrovascular disease in diabetes?
  36. Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue
  37. Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications
  38. C1-esterase inhibitor protects against early vein graft remodeling under arterial blood pressure
  39. Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer
  40. The Influence of Hypoxia and Fibrinogen Variants on the Expansion and Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells
  41. Opposing Effects of the Angiopoietins on the Thrombin-Induced Permeability of Human Pulmonary Microvascular Endothelial Cells
  42. Endothelium—role in regulation of coagulation and inflammation
  43. Perivascular Adipose Tissue and Its Role in Type 2 Diabetes and Cardiovascular Disease
  44. Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome*
  45. Molecular weight fibrinogen variants alter gene expression and functional characteristics of human endothelial cells
  46. Inhibition of Rho–ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase
  47. Substrate stiffening promotes endothelial monolayer disruption through enhanced physical forces
  48. Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib
  49. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil
  50. THE INTERACTION OF SOLUBLE TIE2 WITH ANGIOPOIETINS AND PULMONARY VASCULAR PERMEABILITY IN SEPTIC AND NONSEPTIC CRITICALLY ILL PATIENTS
  51. The Basement Membrane of Intramyocardial Capillaries Is Thickened in Patients with Acute Myocardial Infarction
  52. Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: a sign of ongoing inflammation
  53. CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
  54. Driving Rho GTPase activity in endothelial cells regulates barrier integrity
  55. Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality
  56. Single and combined effects of αvβ3- and α5β1-integrins on capillary tube formation in a human fibrinous matrix
  57. Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension
  58. Thin-Walled Microvessels in Human Coronary Atherosclerotic Plaques Show Incomplete Endothelial Junctions
  59. Blood outgrowth endothelial cells from cord blood and peripheral blood: angiogenesis-related characteristicsin vitro: reply to rebuttal
  60. Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib
  61. Role of ROCK I/II in vascular branching
  62. Blood outgrowth endothelial cells from cord blood and peripheral blood: angiogenesis-related characteristics in vitro
  63. Plasma Cytokine Levels in Hemolytic Uremic Syndrome
  64. The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury
  65. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
  66. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions
  67. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients
  68. Angiogenic Growth Factors and Their Receptors in First-Trimester Human Decidua of Pregnancies Further Complicated By Preeclampsia or Fetal Growth Restriction
  69. Nuclear targeting of β-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction
  70. Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA/Rho kinase-myosin phosphatase axis
  71. Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
  72. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
  73. Protein Kinase C θ Activation Induces Insulin-Mediated Constriction of Muscle Resistance Arteries
  74. Differential gene expression analysis of tubule forming and non-tubule forming endothelial cells: CDC42GAP as a counter-regulator in tubule formation
  75. Loss of 1p36, gain of 8q24, and loss of 9q34 are associated with stroma percentage of colorectal cancer
  76. Pulmonary embolism causes endomyocarditis in the human heart
  77. TAFI and Pancreatic Carboxypeptidase B Modulate In Vitro Capillary Tube Formation by Human Microvascular Endothelial Cells
  78. Natural Killer Cells and CD4+ T-Cells Modulate Collateral Artery Development
  79. Involvement of Rho Kinase in Endothelial Barrier Maintenance
  80. VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients
  81. Different degrees of vascularization and their relationship to the expression of vascular endothelial growth factor, placental growth factor, angiopoietins, and their receptors in first-trimester decidual tissues
  82. Expression of Vascular Endothelial Growth Factor, Stromal Cell-Derived Factor-1, and CXCR4 in Human Limb Muscle With Acute and Chronic Ischemia
  83. Endogenous RhoA Inhibitor Protects Endothelial Barrier
  84. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-κB-mediated increase of intracellular doxorubicin accumulation
  85. Membrane-type matrix metalloproteinases (MT-MMPs) in human endometrium during the cycle
  86. Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo
  87. Argpyrimidine-modified Heat Shock Protein 27 in human non-small cell lung cancer: A possible mechanism for evasion of apoptosis
  88. Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells
  89. Pericellular Proteases in Angiogenesis and Vasculogenesis
  90. Erratum to: “Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells” [FEBS Lett. 580 (2006) 1565-1570]
  91. Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells
  92. Interaction of Nε (carboxymethyl)lysine- and methylglyoxalmodified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs
  93. Direct grafting of RGD-motif-containing peptide on the surface of polycaprolactone films
  94. Activation of human endothelial cells by tumor necrosis factor-α results in profound changes in the expression of glycosylation-related genes
  95. FGFR1 and the Bloodline of the Vasculature
  96. Chapter 14 Chronic lung vascular hyperpermeability
  97. Involvement of Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Capillary Tube Formation by Human Endometrial Microvascular Endothelial Cells: Role of MT3-MMP
  98. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification
  99. Identification of differentially expressed genes in a renal cell carcinoma tumor model after endostatin-treatment
  100. Nε-(Carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels
  101. Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS
  102. DIFFERENTIAL GENE EXPRESSION BY ANGIOGENIC AND NON-ANGIOGENIC ENDOTHELIUM
  103. Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus
  104. Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix
  105. Potential Role of Platelets in Endothelial Damage Observed During Treatment With Cisplatin, Gemcitabine, and the Angiogenesis Inhibitor SU5416
  106. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function
  107. Endothelial hyperpermeability in vascular leakage
  108. Insulin sensitivity correlates with glycogen synthesis rate, but not with von Willebrand factor in type 2 diabetes
  109. Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients
  110. Intracellular signalling involved in modulating human endothelial barrier function*
  111. Intracellular signalling involved in modulating human endothelial barrier function
  112. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
  113. Perivenous application of fibrin glue reduces early injury to the human saphenous vein graft wall in an ex vivo model
  114. Pathophysiological Role of Amadori-Glycated Proteins in Diabetic Microangiopathy
  115. Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality?
  116. Vero Cytotoxin Binding to Polymorphonuclear Leukocytes among Households with Children with Hemolytic Uremic Syndrome
  117. Enhanced Angiogenic Capacity and Urokinase-Type Plasminogen Activator Expression by Endothelial Cells Isolated from Human Endometrium
  118. NO or H2O2 for Endothelium-Dependent Vasorelaxation : Tetrahydrobiopterin Makes the Difference
  119. The endothelium: vascular control of haemostasis
  120. Decreased Smooth Muscle Cell/Extracellular Matrix Ratio of Media of Femoral Artery in Patients With Atherosclerosis and Hyperhomocysteinemia
  121. Cytoskeletal Effects of Rho-Like Small Guanine Nucleotide-Binding Proteins in the Vascular System
  122. Impact of Apolipoprotein(a) on In Vitro Angiogenesis
  123. Perivenous support reduces early changes in human vein grafts: Studies in whole blood perfused human vein segments
  124. Simvastatin Improves Disturbed Endothelial Barrier Function
  125. Role of RhoA and Rho Kinase in Lysophosphatidic Acid-Induced Endothelial Barrier Dysfunction
  126. Activation of RhoA by Thrombin in Endothelial Hyperpermeability : Role of Rho Kinase and Protein Tyrosine Kinases
  127. Accelerated Atherosclerosis by Placement of a Perivascular Cuff and a Cholesterol-Rich Diet in ApoE*3Leiden Transgenic Mice
  128. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study
  129. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries
  130. Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation
  131. Angiogenesis and anti-angiogenesis: Perspectives for the treatment of solid tumors
  132. Transient and Prolonged Increase in Endothelial Permeability Induced by Histamine and Thrombin : Role of Protein Kinases, Calcium, and RhoA
  133. Inhibition of MMP Synthesis by Doxycycline and Chemically Modified Tetracyclines (CMTs) in Human Endothelial Cells
  134. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries
  135. Monocyte Chemoattractant Protein-1 and Interleukin-8 Levels in Urine and Serum of Patents with Hemolytic Uremic Syndrome
  136. Binding of Human Urokinase-Type Plasminogen Activator to Its Receptor : Residues Involved in Species Specificity and Binding
  137. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure
  138. Role of Endothelial Plasminogen Activators in Fibrinolysis and Repair-Associated Angiogenesis
  139. Let's Understand Nature Better: De- and Regeneration of Autologous and Artificial Small Caliber Vascular Grafts
  140. Role of vascular permeability factor/vascular endothelial growth factor in eye disease
  141. Endothelial Permeability for Macromolecules: Mechanistic Aspects of Pathophysiological Modulation
  142. Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells
  143. Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
  144. Mutants of Basic Fibroblast Growth Factor Identify Different Cellular Response Programs
  145. Nature and origin of the neointima in whole vessel wall organ culture of the human saphenous vein
  146. Expression of cGMP-Dependent Protein Kinase I and Phosphorylation of Its Substrate, Vasodilator-Stimulated Phosphoprotein, in Human Endothelial Cells of Different Origin
  147. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.
  148. Supplementation With Low Doses of Vitamin E Protects LDL From Lipid Peroxidation in Men and Women
  149. cGMP and Nitric Oxide Modulate Thrombin-Induced Endothelial Permeability : Regulation via Different Pathways in Human Aortic and Umbilical Vein Endothelial Cells
  150. The Fibrinolytic System in the Hemolytic Uremic Syndrome: In Vivo and In Vitro Studies
  151. Cyclic-GMP-Mediated Decrease in Permeability of Human Umbilical and Pulmonary Artery Endothelial Cell Monolayers
  152. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor α, interleukin 1 and phorbol ester
  153. Leukaplasmapheresis in meningococcal septic shock
  154. Production of Plasminogen Activators and Matrix Metalloproteinases by Endothelial Cells: Their Role in Fibrinolysis and Local Proteolysis
  155. Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers
  156. Effect of propionyl-L-carnitine on human endothelial cells
  157. Regulation of Plasminogen Activator Production by Endothelial Cells: Role in Fibrinolysis and Local Proteolysis
  158. Passage of low density lipoproteins through monolayers of human arterial endothelial cells. Effects of vasoactive substances in an in vitro model
  159. Immune complexes in sera from patients with rheumatoid vasculitis induce polymorphonuclear cell-mediated injury to endothelial cells
  160. The influence of culture conditions and serum lipids on interleukin-1 production by human monocytes
  161. Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels
  162. Effect of Cyclandelate on Prostacyclin Release and Cytosolic Free Calcium Concentrations in Human Endothelial Cells
  163. Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells
  164. Role of endothelial cells and their products in the modification of low-density lipoproteins
  165. LDL cytotoxicity The state of the art
  166. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2
  167. Characterisation of the binding of apolipoprotein E-free high density lipoprotein to cultured human endothelial cells
  168. In vivo and in vitro catabolism of native and biologically modified LDL
  169. In vitro studies on origin and site of action of enzyme activity responsible for conversion of human proapoprotein A-I into apoprotein A-I
  170. In vivo catabolism of biologically modified LDL
  171. Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay
  172. Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins
  173. Incomplete palmitate oxidation in cell-free systems of rat and human muscles
  174. The metabolismin vitroof human low-density lipoprotein by the human hepatoma cell line Hep G2
  175. Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells
  176. Degradation of branched-chain amino acids and 2-oxo acids in human and rat muscle
  177. Effect of carnitine and branched-chain acylcarnitines on the 2-oxo acid dehydrogenase activity in intact mitochondria of rat muscle
  178. 4-Methyl-2-oxopentanoate oxidation by rat skeletal-muscle mitochondria
  179. An accurate and sensitive assay of long-chain fatty acid oxidation in human skeletal muscle
  180. Palmitate oxidation by rat skeletal muscle mitochondria
  181. Effect of l-carnitine on the oxidation of leucine and valine by rat skeletal muscle
  182. Interaction of Lipoproteins with Cultured Endothelial Cells